View Post

Breast-Conserving Surgery Safe for Deeply Seated Breast Cancer

In In The News by Barbara Jacoby

By: Deborah L. Ungerleider, MD From: medscape.com The study covered in this summary was published on ResearchSquare.com as a preprint and has not yet been peer reviewed. Key Takeaways When performing breast-conserving surgery, the retroglandular approach via incision in the inframammary fold for excision of a retroglandular tumor is feasible and safe. This incision gives better cosmetic results while allowing …

View Post

HER2+ Breast Cancer: Key Takeaways From HER2CLIMB

In Clinical Studies News by Barbara Jacoby

By: Giuseppe Curigliano, MD, PhD From: onclive.com An overview of the latest data demonstrated by the HER2CLIMB study evaluating the efficacy and safety of tucatinib in combination with capecitabine and trastuzumab for patients with relapsed/refractory metastatic HER2-positive breast cancer. Giuseppe Curigliano, MD, PhD: Tucatinib is a highly selective HER2 [human epidermal growth factor receptor 2]–directed tyrosine kinase inhibitor. The specificity …

View Post

Black Women Face Barriers to Breast Cancer Treatment, Study Finds

In In The News by Barbara Jacoby

By: Kara-Marie Hall, RN, BSN, CCRN From: verywellhealth.com Key Takeaways Recent research shows Black women are less likely to be offered hypofractionated radiation therapy as an option for breast cancer treatment. Black women face several inequalities that start from the moment they seek a diagnosis. Access to breast cancer treatment can depend on trust, awareness, and financial resources. Improving healthcare …